Epithelial cell polarization is a determinant in the infectious outcome of immunoglobulin a-mediated entry by Epstein-Barr virus

被引:47
作者
Gan, YJ
Chodosh, J
Morgan, A
Sixbey, JW
机构
[1] ST JUDE CHILDRENS RES HOSP, PROGRAM VIRAL ONCOGENESIS & TUMOUR IMMUNOL, MEMPHIS, TN 38101 USA
[2] UNIV TENNESSEE, COLL MED, DEPT PATHOL, MEMPHIS, TN USA
[3] UNIV TENNESSEE, COLL MED, DEPT PEDIAT, MEMPHIS, TN USA
[4] UNIV BRISTOL, DEPT PATHOL & MICROBIOL, BRISTOL, AVON, ENGLAND
关键词
D O I
10.1128/JVI.71.1.519-526.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Diseases of the nasopharyngeal epithelium due to Epstein-Barr virus (EBV) infection typically occur in chronic virus carriers with preexisting virus-specific antibodies, In vitro studies have shown that EBV-specific immunoglobulin A (IgA) promotes infection of human epithelial cells, otherwise refractory to EBV, via the polymeric immunoglobulin receptor (pIgR), To determine if EBV similarly exploits IgA transport mechanisms in vivo, we examined the fate of IgA-EBV complexes in the blood of mice, where pIgR-mediated transcytosis of IgA immune complexes through hepatocytes eliminates exogenous antigens from the circulation, By PCR analysis we showed hepatobiliary transport of IgA-EBV in viremic mice, but without detectable hepatocellular infection by immunostaining. Because efficient transport of EBV immune complexes might avert an infectious outcome, we modulated the transcytotic pathway in polarized Madin-Darby canine kidney (MDCK) cells transfected with pIgR to determine the effect on viral antigen expression, Like hepatocytes in vivo, MDCK cells in polarized monolayers translocated IgA-EBV from the basal cell face into apical medium without evidence for infection, However, when exposed to IgA-EBV as unpolarized single-cell suspensions, MDCK cells expressed EBV immediate-early and early antigens, These results suggest that pIgR-mediated transcytosis of pIgA-EBV through epithelium facilitates endogenous spread of EBV in long-term virus carriers, with infection being confined to cells with altered polarity from prior cytopathology.
引用
收藏
页码:519 / 526
页数:8
相关论文
共 60 条
[1]   EPSTEIN-BARR VIRUS (EBV) INFECTION OF MURINE L-CELLS EXPRESSING RECOMBINANT HUMAN EBV/C3D RECEPTOR [J].
AHEARN, JM ;
HAYWARD, SD ;
HICKEY, JC ;
FEARON, DT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (23) :9307-9311
[2]   THE SUBCELLULAR ORGANIZATION OF MADIN-DARBY CANINE KIDNEY-CELLS DURING THE FORMATION OF A POLARIZED EPITHELIUM [J].
BACALLAO, R ;
ANTONY, C ;
DOTTI, C ;
KARSENTI, E ;
STELZER, EHK ;
SIMONS, K .
JOURNAL OF CELL BIOLOGY, 1989, 109 (06) :2817-2832
[3]   DEVELOPMENT OF CELL-SURFACE POLARITY IN THE EPITHELIAL MADIN-DARBY CANINE KIDNEY (MDCK) CELL-LINE [J].
BALCAROVASTANDER, J ;
PFEIFFER, SE ;
FULLER, SD ;
SIMONS, K .
EMBO JOURNAL, 1984, 3 (11) :2687-2694
[4]   CHARACTERIZATION OF AN EPSTEIN-BARR-VIRUS RECEPTOR ON HUMAN EPITHELIAL-CELLS [J].
BIRKENBACH, M ;
XIAO, T ;
BRADBURY, LE ;
TEDDER, TF ;
KIEFF, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1405-1414
[5]   EFFECT OF NOCODAZOLE ON VESICULAR TRAFFIC TO THE APICAL AND BASOLATERAL SURFACES OF POLARIZED MDCK CELLS [J].
BREITFELD, PP ;
MCKINNON, WC ;
MOSTOV, KE .
JOURNAL OF CELL BIOLOGY, 1990, 111 (06) :2365-2373
[6]  
BROWN TA, 1982, J IMMUNOL, V128, P2183
[7]   Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity [J].
Burns, JW ;
SiadatPajouh, M ;
Krishnaney, AA ;
Greenberg, HB .
SCIENCE, 1996, 272 (5258) :104-107
[8]  
CAPLAN MJ, 1986, CELL, V46, P623, DOI 10.1016/0092-8674(86)90888-3
[9]   IDENTIFICATION OF CELLULAR TARGET GENES OF THE EPSTEIN-BARR-VIRUS TRANSACTIVATOR ZTA - ACTIVATION OF TRANSFORMING GROWTH-FACTOR BETA-IGH3 (TGF-BETA-IGH3) AND TGF-BETA-1 [J].
CAYROL, C ;
FLEMINGTON, EK .
JOURNAL OF VIROLOGY, 1995, 69 (07) :4206-4212
[10]   TRANSFORMING GROWTH FACTOR-BETA SPECIFICALLY ENHANCES IGA PRODUCTION BY LIPOPOLYSACCHARIDE-STIMULATED MURINE LYMPHOCYTES-B [J].
COFFMAN, RL ;
LEBMAN, DA ;
SHRADER, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (03) :1039-1044